|
US3202654A
(en)
|
1962-04-27 |
1965-08-24 |
Bristol Myers Co |
6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
|
|
GB1051723A
(OSRAM)
|
1962-04-27 |
|
|
|
|
US3252970A
(en)
|
1963-02-27 |
1966-05-24 |
Ciba Geigy Corp |
Aromatization
|
|
BE631632A
(OSRAM)
|
1963-04-26 |
|
|
|
|
US3268558A
(en)
|
1964-11-05 |
1966-08-23 |
Ortho Pharma Corp |
1-r-2, 4-dinitropyrroles
|
|
US3458515A
(en)
|
1966-07-21 |
1969-07-29 |
American Home Prod |
Piperazine substituted pyrroles
|
|
GB1208014A
(en)
|
1967-03-23 |
1970-10-07 |
Glaxo Lab Ltd |
Cephalosporins
|
|
US3573294A
(en)
|
1968-03-14 |
1971-03-30 |
Glaxo Lab Ltd |
7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
|
|
BE790747A
(fr)
|
1971-10-30 |
1973-02-15 |
Whitefin Holding Sa |
Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
|
|
GB1476503A
(en)
|
1973-06-21 |
1977-06-16 |
Sterling Drug Inc |
1-arylamino-and 1-arylimino-pyrroles and preparation thereof
|
|
BE848465A
(fr)
|
1976-11-18 |
1977-03-16 |
|
Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
|
|
US4316900A
(en)
|
1977-10-05 |
1982-02-23 |
Ciba-Geigy Corporation |
Piperazinopyrrolobenzodiazepines
|
|
JPS57142966A
(en)
|
1981-02-27 |
1982-09-03 |
Sagami Chem Res Center |
(1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
|
|
JPS57144255A
(en)
|
1981-03-03 |
1982-09-06 |
Sagami Chem Res Center |
Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
|
|
US4761424A
(en)
|
1985-10-01 |
1988-08-02 |
Warner-Lambert Company |
Enolamides, pharmaceutical compositions and methods for treating inflammation
|
|
FR2601368B1
(fr)
|
1986-07-08 |
1989-04-07 |
Synthelabo |
Derives de nitrofuranne, leur preparation et leur application en therapeutique.
|
|
AU650953B2
(en)
|
1991-03-21 |
1994-07-07 |
Novartis Ag |
Inhaler
|
|
US5637592A
(en)
|
1994-07-12 |
1997-06-10 |
Janssen Pharmaceutica N.V. |
Acyl derivatives of azolones
|
|
ES2208685T3
(es)
|
1994-07-21 |
2004-06-16 |
Eli Lilly And Company |
Inhibidores de indolizina spla2.
|
|
EP0823423B1
(en)
|
1995-04-28 |
2004-06-16 |
Banyu Pharmaceutical Co., Ltd. |
1,4-disubstituted piperidine derivatives
|
|
EP0747756B1
(en)
|
1995-06-06 |
2000-05-24 |
Agfa-Gevaert N.V. |
Photographic materials
|
|
JPH09249669A
(ja)
|
1996-03-13 |
1997-09-22 |
Ono Pharmaceut Co Ltd |
縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
|
|
DE69819721T2
(de)
|
1997-06-13 |
2004-09-23 |
Cydex Inc., Overland Park |
Zusammensetzung mit erhöhter lagerstabilität enthaltend cyclodextrin und wirkstoffe oder wirkstoff-vorstufen, die in wasserunlösliche komponenten zersetzt werden
|
|
PT901786E
(pt)
|
1997-08-11 |
2007-08-07 |
Pfizer Prod Inc |
Disperções farmacêuticas sólidas com biodisponibilidade melhorada
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
HUP0102923A3
(en)
|
1998-06-03 |
2002-01-28 |
Gpi Nil Holdings Inc Wilmingto |
Aza-heterocyclic compounds used to treat neurological disorders and hair loss and pharmaceutical compositions containing them
|
|
EP1027887B1
(en)
|
1999-02-10 |
2008-08-13 |
Pfizer Products Inc. |
Matrix controlled release device
|
|
CA2372691C
(en)
|
1999-05-04 |
2009-11-17 |
Janssen Pharmaceutica N.V. |
Antifungal ethers
|
|
WO2001008572A1
(de)
|
1999-07-30 |
2001-02-08 |
Norbert Heske |
Kanülenanordnung zum einbringen endoskopischer instrumente in einen menschlichen oder tierischen körper
|
|
EP1239835B1
(en)
|
1999-12-23 |
2013-03-20 |
Bend Research, Inc. |
Pharmaceutical compositions providing enhanced drug concentrations
|
|
GB0011089D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (11)
|
|
US7202239B2
(en)
|
2001-04-12 |
2007-04-10 |
Wyeth |
Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
|
|
US6825201B2
(en)
|
2001-04-25 |
2004-11-30 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic amidopiperazine derivatives
|
|
WO2002098876A1
(en)
|
2001-06-06 |
2002-12-12 |
Vertex Pharmaceuticals Incorporated |
Cak inhibitors and uses thereof
|
|
IL159438A0
(en)
|
2001-06-20 |
2004-06-01 |
Daiichi Seiyaku Co |
Diamine derivatives
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
WO2003063822A2
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
|
PL371593A1
(en)
|
2002-02-01 |
2005-06-27 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
|
EP1476163A4
(en)
|
2002-02-23 |
2009-05-27 |
Bristol Myers Squibb Co |
METHOD FOR TREATING HIV INFECTION BY PREVENTING INTERACTION OF CD4 AND GP120
|
|
JP2006500387A
(ja)
|
2002-08-15 |
2006-01-05 |
雲清 劉 |
固形ナノ医薬およびその調製方法
|
|
US20050032871A1
(en)
|
2002-09-03 |
2005-02-10 |
Sugen, Inc. |
Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
|
|
CA2517034A1
(en)
|
2003-03-13 |
2004-09-30 |
Synta Pharmaceuticals Corp. |
Fused pyrrole compounds
|
|
FR2854079B1
(fr)
|
2003-04-25 |
2007-11-30 |
Pf Medicament |
Procede de preparation de complexes moleculaires
|
|
CL2004001884A1
(es)
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
WO2005040116A2
(en)
|
2003-10-24 |
2005-05-06 |
Schering Aktiengesellschaft |
Indolinone derivatives and their use in treating disease-states such as cancer
|
|
ATE409462T1
(de)
|
2004-05-28 |
2008-10-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer
|
|
US20060058286A1
(en)
|
2004-09-16 |
2006-03-16 |
Mark Krystal |
Methods of treating HIV infection
|
|
EP1844078B1
(en)
|
2005-02-03 |
2016-09-28 |
Bend Research, Inc |
Pharmaceutical compositions with enhanced performance
|
|
US7842810B2
(en)
|
2005-03-31 |
2010-11-30 |
Janssen Pharmaceutica, Nv |
Bicyclic pyrazole compounds as antibacterial agents
|
|
AR053713A1
(es)
|
2005-04-20 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos como agentes terapeuticos
|
|
WO2006123145A1
(en)
|
2005-05-18 |
2006-11-23 |
F2G Ltd |
Antifungal agents
|
|
WO2007009083A2
(en)
|
2005-07-12 |
2007-01-18 |
Acadia Pharmaceuticals Inc. |
Compounds with activity at retinoic acid receptors
|
|
WO2007015866A2
(en)
|
2005-07-20 |
2007-02-08 |
Kalypsys, Inc. |
Inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
NZ571934A
(en)
|
2006-03-20 |
2012-05-25 |
Vertex Pharma |
Methods of spray drying formulations of vx-950 (telaprevir)
|
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
|
US20080118500A1
(en)
|
2006-11-16 |
2008-05-22 |
Taiwan Liposome Company |
Sustained releasing composition via local injection for treating eye diseases
|
|
GB0623209D0
(en)
|
2006-11-21 |
2007-01-03 |
F2G Ltd |
Antifungal agents
|
|
JP5508859B2
(ja)
|
2007-01-26 |
2014-06-04 |
アイエスピー インヴェストメンツ インコーポレイテッド |
噴霧乾燥製品を製造するための調剤処理方法
|
|
CN101260086B
(zh)
|
2007-03-06 |
2011-08-10 |
中国科学院上海药物研究所 |
蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
|
|
GB0710121D0
(en)
|
2007-05-25 |
2007-07-04 |
F2G Ltd |
Antifungal agents
|
|
US20100215747A1
(en)
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
AU2009239778B2
(en)
*
|
2008-04-24 |
2014-03-13 |
F2G Ltd |
Pyrrole antifungal agents
|
|
GB0809773D0
(en)
|
2008-05-29 |
2008-07-09 |
F2G Ltd |
Antifungal combination therapy
|
|
US20100093872A1
(en)
|
2008-10-15 |
2010-04-15 |
Erimos Pharmaceuticals Llc |
Stable aqueous formulations of water insoluble or poorly soluble drugs
|
|
CA2760305A1
(en)
|
2009-04-28 |
2010-11-04 |
Boehringer Ingelheim International Gmbh |
Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
|
|
US9040033B2
(en)
|
2010-06-14 |
2015-05-26 |
Dow Global Technologies Llc |
Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
|
|
EP2611529B1
(en)
|
2010-09-03 |
2019-01-23 |
Bend Research, Inc. |
Spray-drying method
|
|
WO2012060448A1
(ja)
|
2010-11-05 |
2012-05-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗真菌剤としての併用医薬組成物
|
|
CN102805733B
(zh)
|
2011-06-01 |
2016-03-09 |
日东电工株式会社 |
颗粒制剂及其制造方法
|
|
SG11201401597TA
(en)
|
2011-11-29 |
2014-05-29 |
Jurox Pty Ltd |
Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
|
|
KR20140146181A
(ko)
|
2012-04-11 |
2014-12-24 |
다우 글로벌 테크놀로지스 엘엘씨 |
특정 치환체 분포를 갖는 에스테르화된 셀룰로즈 에테르
|
|
WO2014031422A1
(en)
|
2012-08-24 |
2014-02-27 |
Dow Global Technologies Llc |
Novel hydroxyalkyl methyl cellulose acetate succinates
|
|
CN104736572B
(zh)
|
2012-08-24 |
2017-09-05 |
陶氏环球技术有限责任公司 |
部分交联的酯化纤维素醚
|
|
BR112015015758B1
(pt)
|
2013-01-22 |
2022-01-04 |
F. Hoffmann-La Roche Ag |
Dispersão sólida, formulação sólida de dose unitária, preparação farmacêutica e uso de uma dispersão sólida
|
|
DK3021832T3
(da)
|
2013-07-19 |
2021-05-25 |
Boehringer Ingelheim Vetmedica Gmbh |
Konserverede etherificerede cyclodextrinderivater indeholdende flydende vandig farmaceutisk sammensætning
|
|
WO2015007759A1
(en)
|
2013-07-19 |
2015-01-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
EP3076951B1
(en)
|
2013-12-05 |
2020-09-30 |
Celal Albayrak |
Process for the production of drug formulations for oral administration
|
|
PT107568B
(pt)
|
2014-03-31 |
2018-11-05 |
Hovione Farm S A |
Processo de secagem por atomização para a produção de pós com propriedades melhoradas.
|
|
MX2017006447A
(es)
|
2014-11-21 |
2018-01-30 |
F2G Ltd |
Agentes antifungicos.
|
|
GB201609222D0
(en)
*
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|